Vaccine Contract Manufacturing Market: Global Market Size, Forecast, Insights, and Competitive Landscape
The global vaccine contract manufacturing market is expected to grow at a CAGR of around 9.4% during 2025-2034. This report on global vaccine contract manufacturing market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global vaccine contract manufacturing market by segmenting the market based on process process type, vaccine type, scale of operation, service, application, end user and region. Also, detailed profiles of companies operating in the vaccine contract manufacturing market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.
Market Drivers
● Increasing Awareness
● Rising Demands of Generic Medication
● Increasing Demands of Cell and Gene Therapy
Market Challenges
● Outsourcing by Well-Established Vaccine Makers is Limited
Historical & Forecast Period
Base Year: 2024
Historical Period: 2020-2024
Forecast Period: 2025-2034
Market by Process Type
● Upstream
Mammalian Expression Systems
Bacterial Expression Systems
Yeast Expression Systems
Baculovirus/Insect Expression Systems
Others
● Downstream
Fill and Finish Operations
Analytical and QC studies
Packaging
Market by Vaccine Type
● Subunit Vaccines
● Live Attenuated Vaccines
● Conjugate Vaccines
● Inactivated Vaccines
● Recombinant Vector Vaccines
● Toxoid Vaccines
● Synthetic Vaccines
● Others
Market by Scale of Operation
● Commercial
● Pre-Clinical
● Clinical
Market by Service
● Bulk Product
● Fill Finish
Market by Application
● Human Use
● Veterinary
Market by End User
● Pharmaceutical Companies
● Biotech Companies
● Others
Market by Region
• Europe
Germany
United Kingdom
France
Italy
Spain
Russia
Netherlands
Rest of Europe
• North America
United States
Canada
• Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Rest of Asia Pacific
• Latin America
Mexico
Brazil
Argentina
Rest of Latin America
• Middle East & Africa
Saudi Arabia
Turkey
Iran
Rest of Middle East & Africa
- 1. Preface
- 1.1 Objective
- 1.2 Target Audience & Key Offerings
- 1.3 Report’s Scope
- 1.4 Research Methodology
- 1.4.1 Phase I
- 1.4.2 Phase II
- 1.4.3 Phase III
- 1.5 Assumptions
- 2. Key Insights
- 3. Global Vaccine Contract Manufacturing Market
- 3.1. Introduction
- 3.2. Market Drivers
- 3.3. Market Challenges
- 4. Global Vaccine Contract Manufacturing Market Analysis
- 4.1. Market Portraiture
- 4.2. Market Size
- 4.3. Market Forecast
- 4.4. Impact of COVID-19
- 5. Global Vaccine Contract Manufacturing Market by Process Type
- 5.1. Introduction
- 5.2. Upstream
- 5.3. Downstream
- 6. Global Vaccine Contract Manufacturing Market by Vaccine Type
- 6.1. Introduction
- 6.2. Subunit Vaccines
- 6.3. Live Attenuated Vaccines
- 6.4. Conjugate Vaccines
- 6.5. Inactivated Vaccines
- 6.6. Recombinant Vector Vaccines
- 6.7. Toxoid Vaccines
- 6.8. Synthetic Vaccines
- 6.9. Others
- 7. Global Vaccine Contract Manufacturing Market by Scale of Operation
- 7.1. Introduction
- 7.2. Commercial
- 7.3. Pre-Clinical
- 7.4. Clinical
- 8. Global Vaccine Contract Manufacturing Market by Service
- 8.1. Introduction
- 8.2. Bulk Product
- 8.3. Fill Finish
- 9. Global Vaccine Contract Manufacturing Market by Application
- 9.1. Introduction
- 9.2. Human Use
- 9.3. Veterinary
- 10. Global Vaccine Contract Manufacturing Market by End User
- 10.1. Introduction
- 10.2. Pharmaceutical Companies
- 10.3. Biotech Companies
- 10.4. Others
- 11. Global Vaccine Contract Manufacturing Market by Region
- 11.1. Introduction
- 11.2. Europe
- 11.2.1. Germany
- 11.2.2. United Kingdom
- 11.2.3. France
- 11.2.4. Italy
- 11.2.5. Spain
- 11.2.6. Russia
- 11.2.7. Netherlands
- 11.2.8. Rest of the Europe
- 11.3. North America
- 11.3.1. United States
- 11.3.2. Canada
- 11.4. Asia Pacific
- 11.4.1. China
- 11.4.2. Japan
- 11.4.3. India
- 11.4.4. South Korea
- 11.4.5. Australia
- 11.4.6. Indonesia
- 11.4.7. Rest of the Asia Pacific
- 11.5. Latin America
- 11.5.1. Mexico
- 11.5.2. Brazil
- 11.5.3. Argentina
- 11.5.4. Rest of Latin America
- 11.6. Middle East & Africa
- 11.6.1. Saudi Arabia
- 11.6.2. Turkey
- 11.6.3. Iran
- 11.6.4. United Arab Emirates
- 11.6.5. Rest of Middle East & Africa
- 12. SWOT Analysis
- 13. Porter’s Five Forces
- 14. Market Value Chain Analysis
- 15. Competitive Landscape
- 15.1. Competitive Scenario
- 15.2. Company Profiles
- 15.2.1. Albany Molecular Research Inc
- 15.2.2. Merck KGaA
- 15.2.3. Ajinomoto Co. Inc
- 15.2.4. Boehringer Ingelheim
- 15.2.5. Catalent Inc
- 15.2.6. Cobra Biologics Limited (Charles River Laboratories International Inc.)
- 15.2.7. Cytovance Biologics Inc. (Hepalink USA Inc.)
- 15.2.8. Fujifilm Holdings Corporation
- 15.2.9. GlaxoSmithKline
- 15.2.10. ICON plc
- 15.2.11. IDT Biologika GmbH
- 15.2.12. Lonza Group AG
- 15.2.13. Merck KGaA
- 15.2.14. Pfizer
- 15.2.15. Pharmaceutical Product Development LLC
- 15.2.16. PRA Health Sciences Inc.
- 15.2.17. Recipharm
- 15.2.18. Serum Institute of India
- List of Figures
- Figure 1: Global Vaccine Contract Manufacturing Market (in US$ Million), 2020-2024
- Figure 2: Global Vaccine Contract Manufacturing Market by Process Type, 2024
- Figure 3: Global Vaccine Contract Manufacturing Market by Vaccine Type, 2024
- Figure 4: Global Vaccine Contract Manufacturing Market by Scale of Operation, 2024
- Figure 5: Global Vaccine Contract Manufacturing Market by Service, 2024
- Figure 6: Global Vaccine Contract Manufacturing Market by Application, 2024
- Figure 7: Global Vaccine Contract Manufacturing Market by End User, 2024
- Figure 8: Global Vaccine Contract Manufacturing Market by Region, 2024
- Figure 9: Global Vaccine Contract Manufacturing Market (in US$ Million), 2025-2034
- Figure 10: Global Vaccine Contract Manufacturing Market by Process Type (in %), 2024 & 2034
- Figure 11: Global Upstream Vaccine Contract Manufacturing Market (in US$ Million), 2020-2024
- Figure 12: Global Upstream Vaccine Contract Manufacturing Market (in US$ Million), 2025-2034
- Figure 13: Global Downstream Vaccine Contract Manufacturing Market (in US$ Million), 2020-2024
- Figure 14: Global Downstream Vaccine Contract Manufacturing Market (in US$ Million), 2025-2034
- Figure 15: Global Vaccine Contract Manufacturing Market by Vaccine Type (in %), 2024 & 2034
- Figure 16: Global Subunit Vaccine Contract Manufacturing Market (in US$ Million), 2020-2024
- Figure 17: Global Subunit Vaccine Contract Manufacturing Market (in US$ Million), 2025-2034
- Figure 18: Global Live Attenuated Vaccine Contract Manufacturing Market (in US$ Million), 2020-2024
- Figure 19: Global Live Attenuated Vaccine Contract Manufacturing Market (in US$ Million), 2025-2034
- Figure 20: Global Conjugate Vaccine Contract Manufacturing Market (in US$ Million), 2020-2024
- Figure 21: Global Conjugate Vaccine Contract Manufacturing Market (in US$ Million), 2025-2034
- Figure 22: Global Inactivated Vaccine Contract Manufacturing Market (in US$ Million), 2020-2024
- Figure 23: Global Inactivated Vaccine Contract Manufacturing Market (in US$ Million), 2025-2034
- Figure 24: Global Recombinant Vector Vaccine Contract Manufacturing Market (in US$ Million), 2020-2024
- Figure 25: Global Recombinant Vector Vaccine Contract Manufacturing Market (in US$ Million), 2025-2034
- Figure 26: Global Toxoid Vaccine Contract Manufacturing Market (in US$ Million), 2020-2024
- Figure 27: Global Toxoid Vaccine Contract Manufacturing Market (in US$ Million), 2025-2034
- Figure 28: Global Synthetic Vaccine Contract Manufacturing Market (in US$ Million), 2020-2024
- Figure 29: Global Synthetic Vaccine Contract Manufacturing Market (in US$ Million), 2025-2034
- Figure 30: Global Other Vaccine Types Vaccine Contract Manufacturing Market (in US$ Million), 2020-2024
- Figure 31: Global Other Vaccine Types Vaccine Contract Manufacturing Market (in US$ Million), 2025-2034
- Figure 32: Global Vaccine Contract Manufacturing Market by Scale of Operation (in %), 2024 & 2034
- Figure 33: Global Commercial Vaccine Contract Manufacturing Market (in US$ Million), 2020-2024
- Figure 34: Global Commercial Vaccine Contract Manufacturing Market (in US$ Million), 2025-2034
- Figure 35: Global Pre-Clinical Vaccine Contract Manufacturing Market (in US$ Million), 2020-2024
- Figure 36: Global Pre-Clinical Vaccine Contract Manufacturing Market (in US$ Million), 2025-2034
- Figure 37: Global Clinical Vaccine Contract Manufacturing Market (in US$ Million), 2020-2024
- Figure 38: Global Clinical Vaccine Contract Manufacturing Market (in US$ Million), 2025-2034
- Figure 39: Global Vaccine Contract Manufacturing Market by Service (in %), 2024 & 2034
- Figure 40: Global Bulk Product Vaccine Contract Manufacturing Market (in US$ Million), 2020-2024
- Figure 41: Global Bulk Product Vaccine Contract Manufacturing Market (in US$ Million), 2025-2034
- Figure 42: Global Fill Finish Vaccine Contract Manufacturing Market (in US$ Million), 2020-2024
- Figure 43: Global Fill Finish Vaccine Contract Manufacturing Market (in US$ Million), 2025-2034
- Figure 44: Global Vaccine Contract Manufacturing Market by Application (in %), 2024 & 2034
- Figure 45: Global Human Use Vaccine Contract Manufacturing Market (in US$ Million), 2020-2024
- Figure 46: Global Human Use Vaccine Contract Manufacturing Market (in US$ Million), 2025-2034
- Figure 47: Global Veterinary Vaccine Contract Manufacturing Market (in US$ Million), 2020-2024
- Figure 48: Global Veterinary Vaccine Contract Manufacturing Market (in US$ Million), 2025-2034
- Figure 49: Global Vaccine Contract Manufacturing Market by End User (in %), 2024 & 2034
- Figure 50: Global Pharmaceutical Companies Vaccine Contract Manufacturing Market (in US$ Million), 2020-2024
- Figure 51: Global Pharmaceutical Companies Vaccine Contract Manufacturing Market (in US$ Million), 2025-2034
- Figure 52: Global Biotech Companies Vaccine Contract Manufacturing Market (in US$ Million), 2020-2024
- Figure 53: Global Biotech Companies Vaccine Contract Manufacturing Market (in US$ Million), 2025-2034
- Figure 54: Global Other End Users Vaccine Contract Manufacturing Market (in US$ Million), 2020-2024
- Figure 55: Global Other End Users Vaccine Contract Manufacturing Market (in US$ Million), 2025-2034
- Figure 56: Global Vaccine Contract Manufacturing Market by Region (in %), 2024 & 2034
- Figure 57: Europe Vaccine Contract Manufacturing Market (in US$ Million), 2020-2024
- Figure 58: Europe Vaccine Contract Manufacturing Market (in US$ Million), 2025-2034
- Figure 59: Europe Vaccine Contract Manufacturing Market by Country (in %), 2024 & 2034
- Figure 60: Germany Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
- Figure 61: United Kingdom Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
- Figure 62: France Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
- Figure 63: Italy Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
- Figure 64: Spain Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
- Figure 65: Russia Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
- Figure 66: Netherlands Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
- Figure 67: North America Vaccine Contract Manufacturing Market (in US$ Million), 2020-2024
- Figure 68: North America Vaccine Contract Manufacturing Market (in US$ Million), 2025-2034
- Figure 69: North America Vaccine Contract Manufacturing Market by Country (in %), 2024 & 2034
- Figure 70: United States Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
- Figure 71: Canada Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
- Figure 72: Asia Pacific Vaccine Contract Manufacturing Market (in US$ Million), 2020-2024
- Figure 73: Asia Pacific Vaccine Contract Manufacturing Market (in US$ Million), 2025-2034
- Figure 74: Asia Pacific Vaccine Contract Manufacturing Market by Country (in %), 2024 & 2034
- Figure 75: China Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
- Figure 76: Japan Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
- Figure 77: India Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
- Figure 78: South Korea Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
- Figure 79: Australia Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
- Figure 80: Indonesia Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
- Figure 81: Latin America Vaccine Contract Manufacturing Market (in US$ Million), 2020-2024
- Figure 82: Latin America Vaccine Contract Manufacturing Market (in US$ Million), 2025-2034
- Figure 83: Latin America Vaccine Contract Manufacturing Market by Country (in %), 2024 & 2034
- Figure 84: Mexico Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
- Figure 85: Brazil Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
- Figure 86: Argentina Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
- Figure 87: Middle East & Africa Vaccine Contract Manufacturing Market (in US$ Million), 2020-2024
- Figure 88: Middle East & Africa Vaccine Contract Manufacturing Market (in US$ Million), 2025-2034
- Figure 89: Middle East & Africa Vaccine Contract Manufacturing Market by Country (in %), 2024 & 2034
- Figure 90: Saudi Arabia Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
- Figure 91: Turkey Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
- Figure 92: Iran Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
- Figure 93: UAE Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
- Figure 94: Rest of Middle East & Africa Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
- Figure 95: Market Value Chain
- List of Tables
- Table 1: Global Vaccine Contract Manufacturing Market Portraiture
- Table 2: Global Vaccine Contract Manufacturing Market by Process Type (in US$ Million), 2024 & 2034
- Table 3: Global Vaccine Contract Manufacturing Market by Vaccine Type (in US$ Million), 2024 & 2034
- Table 4: Global Vaccine Contract Manufacturing Market by Scale of Operation (in US$ Million), 2024 & 2034
- Table 5: Global Vaccine Contract Manufacturing Market by Service (in US$ Million), 2024 & 2034
- Table 6: Global Vaccine Contract Manufacturing Market by Application (in US$ Million), 2024 & 2034
- Table 7: Global Vaccine Contract Manufacturing Market by End User (in US$ Million), 2024 & 2034
- Table 8: Global Vaccine Contract Manufacturing Market by Region (in US$ Million), 2024 & 2034
- Table 9: Europe Vaccine Contract Manufacturing Market by Country (in US$ Million), 2024 & 2034
- Table 10: North America Vaccine Contract Manufacturing Market by Country (in US$ Million), 2024 & 2034
- Table 11: Asia Pacific Vaccine Contract Manufacturing Market by Country (in US$ Million), 2024 & 2034
- Table 12: Latin America Vaccine Contract Manufacturing Market by Country (in US$ Million), 2024 & 2034
- Table 13: Middle East & Africa Vaccine Contract Manufacturing Market by Country (in US$ Million), 2024 & 2034
- Table 14: List of Key Players
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook